A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus
Clinical trial NCT04050553 · COMPLETED
Trial details
- NCT number
- NCT04050553
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-24
- Primary completion
- 2022-01-25
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.